R-Evolution Worldwide in Africa for United Nations Sustainable Development Goal n. 3 “Ensure healthy lives and promote well-being for all at all ages”.
R-Evolution aims to contribute to African public health advances through strategic research activities. The vision is to increase the involvement of the Sub-Saharan African (SSA) countries in ethically and scientifically sound biomedical research and clinical trials addressing specifically SSA public health challenges.
R-Evolution Worldwide supports also research projects:
– to develop new interventional treatments, medicines, vaccines, diagnostics
– to improve the access to existing healthcare tools
– to strengthening research ethics and regulatory capacities.
Currently, R-Evolution Worldwide is involved in the following projects consortia, all scientifically coordinated by African researchers:
| Acronym (click on it to access the website) | Project title | Status | Sub-Sharan African countries involved |
LiberHetica |
Increasing the ethics capacity of oversight for clinical trials in Liberia by establishing European-African collaborations that facilitates implementation of efficient processes, harmonized procedures, standardized guidelines and educative training programs (grant n. CSA2018ERC-2327 EDCTP). | Completed | Liberia |
Africlinique |
A European-African network for strengthening the regulatory capacity for clinical research and pharmacovigilance in Central Africa: implementation of harmonized procedures, efficient guidelines and training programs (gent n. CSA2018ERC-2319 EDCTP) | Completed | Republic of Congo, Cameroon, (Gabon) |
AfriEthique |
A European-African network for strengthening the Ethics capacity for clinical research review in the Democratic Republic of Congo, the Republic of Central Africa, Chad, and the Republic of Congo (grant n. CSA2019ERC-2675 EDCTP). | Ongoing | Democratic Republic of Congo, the Republic of Central Africa, Chad, Republic of Congo, (Gabon) |
| ITAIL-COVID-19
|
Integrated Testing Approaches and Intensive Laboratory training as strategy against COVID-19 spread in Congo-Brazzaville (grant n. RIA2020EF-2947 ) | Completed | Republic of Congo |
SEARCH |
Increasing the regulatory capacities for review of clinical trials in Southern Africa by establishing European-African collaborations facilitating the implementation of efficient procedures (SEARCH SouthErn Africa Regulatory for Clinical researcH) (grant n. CSA2019ERC-2688 EDCTP) | Completed | Mozambique, Botswana, Lesotho, Eswatini |
INTEGRATION |
INcreasing the upTakE of IPTp-SP throuGh Seasonal MalaRiA ChemoprevenTION channel delivery (EDCTP2 grant n. RIA2020S-3302) | Ongoing | Mali, Burkina Faso |
NeuroSolve |
Implementation of superior treatment regimen and improved patient pathway for neurocysticercosis in Sub-Saharan Africa (EDCTP3 grant n. HORIZON-JU-RIA 101103306) | Ongoing | Tanzania, Zambia |
| SEARCH II | Strengthening Regulatory Capacities for Clinical Trials Oversight in Southern Africa: South-South and SouthNorth Collaboration Initiative for Regulatory Bodies (EDCTP3 grant n. HORIZON-JU-CSA 101103195). | Ongoing | Mozambique, Botswana, Lesotho, eSwatini, Zambia and Namibia |
MPOX-PROBE |
Strengthening epidemiological, genomic and community surveillance of Mpox virus the Congo River border between DRC and Republic of Congo (grant n. HORIZON-JU-GH-EDCTP3-2024-Mpox 101195102) |
Ongoing | Republic of Congo, DRC |
IMVACS |
Integrating Malaria VACcine with Seasonal malaria chemoprevention in West Africa- IMVACS” (grant n. GH EDCTP3 JU n. 101160339) | Ongoing | Mali, Burkina Faso |
